Cargando…
Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs
BACKGROUND: Children with comorbidities or danger signs are often excluded from trials evaluating pneumonia treatment. METHODS: We sought to investigate whether the percentage of children with chest-indrawing pneumonia cured at Day 14 was lower among those with HIV infection or exposure, malaria, mo...
Autores principales: | Ginsburg, Amy Sarah, Mvalo, Tisungane, Phiri, Melda, Gadama, Daphne, Chirombo, Claightone, Maliwichi, Madalitso, Hwang, Jun, May, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979154/ https://www.ncbi.nlm.nih.gov/pubmed/33791095 http://dx.doi.org/10.7189/jogh.11.04016 |
Ejemplares similares
-
Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian
children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020) -
Malawian children with fast-breathing pneumonia with and without comorbidities
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Chest radiography in children aged 2–59 months enrolled in the Innovative Treatments in Pneumonia (ITIP) project in Lilongwe Malawi: a secondary analysis
por: Mvalo, Tisungane, et al.
Publicado: (2022) -
Fast-breathing vs chest-indrawing childhood pneumonia: baseline characteristics
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018)